Atlas Trials

Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03

Clinical trial NCT00731029 · COMPLETED

Trial details

NCT number
NCT00731029
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza
Start date
2002-09-01
Primary completion
2003-04-01
Enrollment
239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.